迈瑞医疗 (300760)

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexDeepSeekMSCI China A 50 IndexMSCI Component StocksChina A80 IndexCSI 100 IndexCSI A100 IndexCSI Leading Enterprises IndexNorthbound Heavy PositionsMedical DevicesSTAR and ChiNext 50 IndexGuozheng Growth IndexGuozheng Corporate Governance IndexFund Heavy PositionsLarge Cap GrowthLarge Cap StocksFTSE China A50 IndexCommitment Not to Reduce HoldingsEmerging Markets IndexHundred-Yuan StocksNew Social Security Fund HoldingsHigh-Performing StocksIndustry LeadersTongdaxin 88Northbound Connect Heavy PositionsNon-Cyclical StocksHigh-Dividend StocksChiNext InnovationChiNext Large CapChiNext 50 IndexChiNext IndexChiNext Blue ChipChiNext HealthcareChiNext TechSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexSZSE Governance IndexTech 100 IndexPharma & BiotechTechnology Leaders IndexSZSE Defensive 50 IndexSHS Technology Leaders IndexSZSE Enterprises Composite IndexGreater Bay Area IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexInnovation Demonstration IndexInnovation Engine IndexSZSE 100 Equal Weight IndexEqual Weight 90 IndexZhongchuang Equal Weight IndexCSI Emerging Industries IndexJuchao Large-cap IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexJuchao 100 IndexChiNext Equal Weight IndexCSI 300 Quality IndexCSI 100 Low Volatility IndexCS High Dividend Yield IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE Emerging Industries IndexSZSE GDP IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexSZSE Fundamental 60 IndexCR Foundation IndexCSSW Silk Road IndexCSI Medical IndexExcellent Performance Strategy IndexSZSE Performance IndexCS Precision Medicine IndexChiNext Value IndexNew Virus PreventionCOVID-19 PreventionFTSE Russell ConceptShareholding Increase CommitmentOverseas Expansion LeadersCSI 300 Non-cyclical IndexCNI Emerging Industries IndexTechnology 50 IndexPension Industry IndexPublic Health IndexSHS Greater Bay Area IndexSZSE Responsibility IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexAdvanced Manufacturing IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSTAR Market & ChiNext 50 IndexSZSE Technology IndexCSI Super-large Cap IndexSZSE Leaders IndexCSI 300 ESG Leading IndexSZSE 100 Return IndexCSI Technology IndexTechnology Pioneer IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSZSE Pharmaceutical IndexDividend Quality IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexESG 100 IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCS Pearl River Delta IndexCSI 300 USD (CNH) IndexChiNext Basic IndexHua Xia Bank ESG IndexCS Pharmaceutical Innovation IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSmart Select 300 ESG Leading IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexZhaoyang 100 IndexSZSE Component Index Equal WeightCS Biomedicine IndexCNI A50 IndexPharmaceutical & Health 100 IndexLarge-cap Blue-chip 25 IndexCSI 300 Value Stable IndexCSI 300 Pharmaceutical IndexAH Economic Blue-chip IndexSZSE Fundamental 200 IndexPharmaceutical 50 IndexFundamental 200 IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexChiNext Manufacturing IndexChiNext Growth IndexESG 300 IndexCR New Momentum IndexOrient Securities Competition IndexChina Economic Index GDPLarge-cap Blue-chip 25 USD IndexChiNext Return IndexShenzhen Technology IndexSZSE Fundamental 120 IndexChiNext Emerging IndexFundamental 600 IndexCSI 300 Growth Innovation IndexChiNext Growth IndexPerformance IndexStrategic Emerging Industries 100 IndexGuangdong

K-Line Chart

No K-line data available

Company NameShenzhen Mindray Bio-Medical Electronics Co., Ltd.
Listing Date2018-10-16
Issue Price48.8RMB
Registered Capital121244.139410k RMB
Legal RepresentativeLi Xiting
Registered AddressFloors 1-4, Mindray Building, Keji Nan 12th Road, Nanshan High-Tech Industrial Park, Nanshan District, Shenzhen City, Guangdong Province
IndustryMedical Devices
Main BusinessPrimarily engaged in the research and development, manufacturing, marketing, and services of medical devices. Always customer demand-oriented, committed to providing high-quality products and services to global medical institutions.
Company ProfileMindray was founded in 1991 and is a global leading supplier of medical devices and solutions. Headquartered in Shenzhen, China, Mindray has subsidiaries in 32 countries across North America, Europe, Asia, Africa, and Latin America, with branches in all 31 provinces, municipalities, and autonomous regions of China. With nearly 7,600 employees worldwide, it has formed an extensive global R&D, marketing, and service network. Mindray integrates innovation and closely aligns with clinical needs to help improve medical conditions and reduce healthcare costs for people around the world. Currently, Mindray's products and solutions are used in over 190 countries and regions globally, and in nearly 110,000 medical institutions in China, covering over 99% of top-tier hospitals.

Stock Details

1. Key Indicators

  • Total Shares(W): 121244.14
  • Circulating A-Shares(W): 121240.56
  • Earnings Per Share(RMB): 6.2481
  • Net Assets Per Share(RMB): 32.4120
  • Operating Revenue(W RMB): 2583390.65
  • Total Profit(W RMB): 890161.18
  • Net Profit Attributable to Parent(W RMB): 757004.45
  • Net Profit Growth Rate(%): -28.83
  • Weighted Return on Equity(%): 19.6400
  • Operating Cash Flow Per Share(RMB): 5.9990
  • Undistributed Profit Per Share(RMB): 25.7450
  • Capital Reserve Per Share(RMB): 5.0325

2. Main Business

The main business covers:

  • R&D of medical devices
  • Manufacturing of medical devices
  • Marketing of medical devices
  • Service for medical devices

3. Company Basic Information

  • Company Name: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Listing Date: 2018-10-16
  • Industry: Special Purpose Equipment Manufacturing
  • Address: 1-4/F, Mindray Building, South 12th Road, High-tech Industrial Park, Nanshan District, Shenzhen, Guangdong Province
  • Website: www.mindray.com
  • Company Profile: The company was established through the overall restructuring of Mindray Limited into a joint stock company. On October 17, 2001, Shenzhen Tianjian Xinde Certified Public Accountants issued the "Audit Report" (Xinde Shen Te Shen Bao Zi (2001) No. 56), verifying that as of July 31, 2001, the net assets of Mindray Limited were 86,265,839.55 yuan. On October 18, 2001, the board of directors of Mindray Limited passed a resolution on the establishment of a joint stock company by promotion, agreeing to change Mindray Limited into a joint stock company by way of promotion. The audited net assets of Mindray Limited as of July 31, 2001, amounting to 86,265,839.55 yuan, were converted into 86,000,000 shares of Mindray Medical (with a par value of RMB 1 per share), with the difference of 265,839.55 yuan recorded as capital reserve. All shareholders of Mindray Limited, as promoters, subscribed for the shares of the joint stock company with the net assets corresponding to their respective equity interests in Mindray Limited. On December 18, 2001, the company held its inaugural meeting and first shareholders' meeting, which reviewed and approved the relevant proposals for the overall change of Mindray Limited into a joint stock company. The meeting also reviewed and approved the new articles of association and matters related to the company's establishment, and elected the directors of the first board of directors and the shareholder representative supervisors of the first board of supervisors. On December 26, 2001, the Shenzhen Administration for Industry and Commerce issued the "Business License of Enterprise Legal Person" for the change to a joint stock company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Smartco Development Limited Legal Person 32707.23 26.98
2 Magnifice(HK)Limited Legal Person 29695.10 24.49
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 11666.51 9.62
4 Ever Union(H.K.)Limited Legal Person 4648.24 3.83
5 E Fund ChiNext Board ETF Fund 1169.35 0.96
6 Huatai-PineBridge CSI 300 ETF Fund 1033.58 0.85
7 HuaBao CSI Medical ETF Fund 947.20 0.78
8 National Social Security Fund 113 Portfolio Social Security Fund 772.53 0.64
9 E Fund CSI 300 Healthcare ETF Fund 759.59 0.63
10 Invesco Great Wall Emerging Growth Hybrid Fund A Fund 748.00 0.62

5. Concept Sectors

  • Tongdaxin 88
  • AIGC Concept
  • Pulse Oximeter
  • Pet Economy
  • DeepSeek
  • AI Healthcare
  • Margin Trading
  • Large Cap Stock
  • High-Performance Stock
  • Social Security Fund Heavy Position
  • Fund Heavy Position
  • Industry Leader
  • Recent Low
  • Hundred-Yuan Stock
  • MSCI Constituent
  • Social Security Fund New Entry
  • Northbound Heavy Position
  • Mainland-Hong Kong Stock Connect Heavy
  • Non-Cyclical Stock
  • High Dividend Stock
  • Commitment Not to Reduce
  • CSI 100
  • Galaxy 99
  • Zhongchuang 100
  • Large Cap Growth
  • ChiNext Index
  • SZSE 100
  • SZSE 300
  • SZSE Dividend
  • SZSE Governance
  • Consumption 100
  • SZSE Governance Index
  • SZSE Growth Index
  • SZSE Growth
  • CSI 300
  • ChiNext 50
  • China A80
  • ChiNext 300
  • 300 Non-Cyclical
  • CSI Leaders
  • SZSE Innovation
  • ChiNext Innovation
  • ChiNext Blue Chip
  • ChiNext Large Cap
  • FTSE A50
  • ChiNext Technology
  • ChiNext Healthcare
  • STAR 50
  • Innovation 100
  • 300 ESG
  • MSCI China A50
  • Pearl River Delta
  • SZSE 50
  • CSI A50
  • CSI A100

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information